Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,942 | -6,262 | -4,826 | -2,634 | -7,533 |
| Depreciation Amortization | 13 | 9 | 6 | 3 | 6 |
| Accounts receivable | 71 | 58 | -18 | -25 | -63 |
| Other Working Capital | 116 | 754 | 936 | 805 | 487 |
| Other Operating Activity | 201 | -39 | 32 | 42 | 513 |
| Operating Cash Flow | $-8,540 | $-5,479 | $-3,871 | $-1,809 | $-6,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -53 | -53 | -53 | -51 | -1 |
| Other Investing Activity | 39 | 26 | 19 | 10 | 37 |
| Investing Cash Flow | $-14 | $-27 | $-34 | $-41 | $36 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 159 | 159 | 159 | N/A | N/A |
| Common Stock Issued | 18,458 | 4,802 | 1,970 | N/A | 6,990 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 130 |
| Financing Cash Flow | $18,617 | $4,960 | $2,129 | $N/A | $7,120 |
| Beginning Cash Position | 2,784 | 2,784 | 2,784 | 2,784 | 2,217 |
| End Cash Position | 12,846 | 2,238 | 1,008 | 934 | 2,784 |
| Net Cash Flow | $10,062 | $-546 | $-1,775 | $-1,850 | $566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,540 | -5,479 | -3,871 | -1,809 | -6,590 |
| Capital Expenditure | -53 | -53 | -53 | -51 | -1 |
| Free Cash Flow | -8,593 | -5,532 | -3,924 | -1,860 | -6,591 |